Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 21, Number 10—October 2015

Novel Paramyxoviruses in Bats from Sub-Saharan Africa, 2007–2012

Marinda Mortlock, Ivan V. Kuzmin, Jacqueline Weyer, Amy T. Gilbert, Bernard Agwanda, Charles E. Rupprecht, Louis H. Nel, Teresa Kearney, Jean Malekani, and Wanda MarkotterComments to Author 
Author affiliations: University of Pretoria, Pretoria, South Africa (M. Mortlock, J. Weyer, L.H. Nel, W. Markotter); University of Texas Medical Branch, Galveston, Texas, USA (I.V. Kuzmin); National Institute for Communicable Diseases, Sandringham, South Africa (J. Weyer); US Department of Agriculture, Fort Collins, Colorado, USA (A.T. Gilbert); National Museums of Kenya, Nairobi, Kenya (B. Agwanda); LYSSA LLC, Atlanta, Georgia, USA (C.E. Rupprecht); The Wistar Institute, Philadelphia, Pennsylvania, USA (C.E. Rupprecht); Ditsong National Museum of Natural History, Pretoria (T. Kearney); University of Kinshasa, Kinshasa, Democratic Republic of the Congo (J.M. Malekani)

Main Article

Table 1

African bat species sampled and the number of paramyxovirus sequences detected in sub-Saharan Africa, by country, 2007–2012*

Southern Africa
South Africa
Chaerephon ansorgei (2/0) Neoromicia nana (7/2) Rhinolophus sp. (1/0)
Chaerephon pumilus (8/0) Neoromicia rueppellii (1/0) Rousettus aegyptiacus (18/0)
Epomophorus gambianus (2/0) Neoromicia zuluensis (1/0) Sauromys petrophilus (1/0)
Epomophorus wahlbergi (15/0) Nycteris thebaica (12/1) Scotophilus sp. (12/0)
Eptesicus hottentotus (2/1) Nycticeinops schlieffeni (9/0) Scotophilus dinganii (26/0)
Glauconycteris variegata (5/0) Pipistrellus hesperidus (5/0) Scotophilus leucogaster (2/0)
Hipposideros caffer (6/2) Pipistrellus rusticus (5/0) Scotophilus nigrita (1/0)
Kerivoula argentata (1/1) Pipistrellus sp. (5/0) Scotophilus viridis (3/0)
Miniopterus natalensis (5/0) Rhinolophus darlingi (5/0) Tadarida aegyptiaca (5/0)
Miniopterus sp. (37/0) Rhinolophus denti (3/2) Taphozous mauritianus (2/0)
Mops condylurus (7/0) Rhinolophus fumigatus (2/0)
Neoromicia capensis (16/0) Rhinolophus landeri (1/1)
Neoromicia helios (6/0)
Rhinolophus simulator (2/0)

Nycteris thebaica (4/0)

Eastern Africa
Coleura afra (27/10) Miniopterus natalensis (15/0) Rousettus aegyptiacus (84/2)
Eidolon helvum (15/0) Miniopterus sp. (77/13) Scotoecus sp. (2/0)
Epomophorus labiatus (6/0) Neoromicia sp. (25/0) Scotophilus dinganii (2/0)
Epomophorus wahlbergi (2/0) Nycteris sp. (2/1) Taphozous sp. (1/0)
Hipposideros vittatus (71/0) Otomops martiensseni (40/9) Triaenops afer (16/12)
Hipposideros sp. (8/1) Rhinolophus landeri (12/0)
Miniopterus minor (151/14)
Rhinolophus sp. (14/0)

Central Africa
Chaerephon sp. (32/0) Hipposideros sp. (39/1) Taphozous sp. (12/3)
Eidolon helvum (15/0) Rhinolophus sp. (9/1)
Epomophorus sp. (1/0)
Scotophilus dinganii (1/0)

Democratic Republic of the Congo
Chaerephon pumilus (25/0) Hypsignathus monstrosus (2/0) Myonycteris torquata (8/0)
Chaerephon sp. (22/0) Megaloglossus woermanni (10/0) Myotis sp. (3/0)
Eidolon helvum (22/0) Micropteropus pusillus (1/0) Neoromicia sp. (1/0)
Glauconycteris argentata (1/0) Mimetillus moloneyi (1/0) Pipistrellus sp. (40/20)
Hipposideros fuliginosus (21/3) Miniopterus sp. (41/2) Rhinolophus sp. (1/0)
Hipposideros gigas (2/0)
Mops condylurus (33/0)
Scotophilus dinganii (2/0)
Western Africa
Eidolon helvum (20/0) Hipposideros sp. (3/1) Rousettus aegyptiacus (21/0)
Hipposideros vittatus (8/0) Lissonycteris angolensis (8/0)

*Values are no. samples (no. positive). Boldface indicates implicated species. The sampling protocol was approved by the Institutional Animal Care and Use Committee of the Centers for Disease Control and Prevention; protocol 2096FRAMULX-A3 and The University of Pretoria Animal Ethics Committee (EC054–14).

Main Article

Page created: September 22, 2015
Page updated: September 22, 2015
Page reviewed: September 22, 2015
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.